Bristol-Myers Squibb Net Worth 2006-2018 | BMY

Interactive chart of historical net worth (market cap) for Bristol-Myers Squibb (BMY) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Bristol-Myers Squibb net worth as of March 22, 2019 is $78.63B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $78.630B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $367.316B 16.74
Pfizer (PFE) United States $249.127B 13.95
Merck (MRK) United States $221.869B 18.96
Novartis AG (NVS) Switzerland $215.800B 18.35
Eli Lilly (LLY) United States $132.844B 23.08
Novo Nordisk (NVO) Denmark $123.936B 20.05
AbbVie (ABBV) United States $117.653B 10.08
Sanofi (SNY) France $111.008B 13.70
AstraZeneca (AZN) United Kingdom $107.876B 12.31
GlaxoSmithKline (GSK) United Kingdom $102.325B 13.44